Childhood TB Sequel

Launched by LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE · Apr 5, 2022

Keywords

ClinConnect Summary

The Childhood TB Sequel trial is studying the long-term effects of pulmonary tuberculosis (PTB) in children. Researchers want to understand how PTB can affect children even after they have completed their treatment and to identify any risk factors that may contribute to these ongoing issues. The study will involve children aged 19 years and younger who live in the Greater Banjul Area and have been treated for PTB—either confirmed or suspected—and have been declared cured or completed treatment.

If eligible, participants will visit the study clinic for check-ups over 36 months, where doctors will assess their health, perform breathing tests, and take X-rays to monitor their recovery. Parents or caregivers will need to provide consent for their children's participation. It’s important to note that children who move away from the study area or develop tuberculosis again during the study will not be able to continue with in-person visits, although they may still receive follow-up calls. This trial aims to provide valuable insights into the long-term health of children who have battled PTB, helping to improve care for future patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Aged 19 years and below
• • Reside in the Greater Banjul Area
• • Were diagnosed with either confirmed or unconfirmed PTB
• • Have completed treatment with an outcome of 'cured' or 'treatment completed' according to the Gambia NLTP guideline
• • Parent/caregiver willing to provide written informed consent, as well as assent for the children
• Exclusion Criteria:
• • Relocate from the study area during the follow-up period. If they are reachable by telephone, they will be excluded from study visits in the clinic but will continue to be followed up via telephone calls
• • Develop tuberculosis disease during the follow-up period